| 0 |
VENOUS HAEMORRHAGE |
1 |
0.0032 |
| 1 |
ELECTROCARDIOGRAM T WAVE PEAKED |
1 |
0.0025 |
| 2 |
PERINEAL PAIN |
1 |
0.0014 |
| 3 |
PARASOMNIA |
1 |
0.0014 |
| 4 |
LYMPHADENECTOMY |
1 |
0.0010 |
| 5 |
VAGINAL ODOUR |
1 |
0.0008 |
| 6 |
INFUSION SITE IRRITATION |
1 |
0.0008 |
| 7 |
CARDIOACTIVE DRUG LEVEL INCREASED |
1 |
0.0008 |
| 8 |
VULVOVAGINAL CANDIDIASIS |
1 |
0.0007 |
| 9 |
SEBORRHOEIC DERMATITIS |
1 |
0.0006 |
| 10 |
ESSENTIAL HYPERTENSION |
1 |
0.0005 |
| 11 |
INFUSION SITE INFECTION |
1 |
0.0004 |
| 12 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
2 |
0.0004 |
| 13 |
ANXIETY DISORDER |
1 |
0.0003 |
| 14 |
FAECES SOFT |
2 |
0.0003 |
| 15 |
VULVOVAGINAL DISCOMFORT |
1 |
0.0002 |
| 16 |
SKIN ABRASION |
1 |
0.0002 |
| 17 |
VULVOVAGINAL PAIN |
1 |
0.0002 |
| 18 |
HEPATIC ENZYME ABNORMAL |
1 |
0.0002 |
| 19 |
VEIN DISORDER |
1 |
0.0002 |
| 20 |
TOE AMPUTATION |
1 |
0.0002 |
| 21 |
INCREASED UPPER AIRWAY SECRETION |
1 |
0.0002 |
| 22 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 23 |
SOMNAMBULISM |
1 |
0.0002 |
| 24 |
CROHN'S DISEASE |
1 |
0.0001 |
| 25 |
BLINDNESS TRANSIENT |
1 |
0.0001 |
| 26 |
ACIDOSIS |
1 |
0.0001 |
| 27 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 28 |
HICCUPS |
1 |
0.0001 |
| 29 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
3 |
0.0001 |
| 30 |
SKIN SWELLING |
1 |
0.0001 |
| 31 |
VAGINAL DISCHARGE |
1 |
0.0001 |
| 32 |
DRY THROAT |
1 |
0.0001 |
| 33 |
EUPHORIC MOOD |
1 |
0.0001 |
| 34 |
TRANSFUSION |
1 |
0.0001 |
| 35 |
INTRAOCULAR PRESSURE INCREASED |
1 |
0.0001 |
| 36 |
HYPOPHAGIA |
2 |
0.0001 |
| 37 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 38 |
HAIR TEXTURE ABNORMAL |
1 |
0.0001 |
| 39 |
FREQUENT BOWEL MOVEMENTS |
2 |
0.0001 |
| 40 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 41 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 42 |
BONE LOSS |
1 |
0.0001 |
| 43 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 44 |
MULTIPLE FRACTURES |
1 |
0.0001 |
| 45 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 46 |
HYPERKALAEMIA |
2 |
0.0001 |
| 47 |
THIRST |
1 |
0.0001 |
| 48 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 49 |
RIB FRACTURE |
1 |
0.0000 |
| 50 |
TOOTH LOSS |
1 |
0.0000 |
| 51 |
RETCHING |
1 |
0.0000 |
| 52 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 53 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 54 |
FIBROMYALGIA |
1 |
0.0000 |
| 55 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 56 |
HEPATITIS |
1 |
0.0000 |
| 57 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 58 |
ANHEDONIA |
1 |
0.0000 |
| 59 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 60 |
WOUND |
1 |
0.0000 |
| 61 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 62 |
INJECTION SITE RASH |
1 |
0.0000 |
| 63 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 64 |
OSTEONECROSIS |
1 |
0.0000 |
| 65 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 66 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 67 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 68 |
HEART RATE DECREASED |
1 |
0.0000 |
| 69 |
MYELOSUPPRESSION |
1 |
0.0000 |
| 70 |
DYSURIA |
1 |
0.0000 |
| 71 |
EYE SWELLING |
1 |
0.0000 |
| 72 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 73 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 74 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 75 |
DISORIENTATION |
1 |
0.0000 |
| 76 |
OSTEOPOROSIS |
1 |
0.0000 |
| 77 |
TREATMENT FAILURE |
2 |
0.0000 |
| 78 |
COMPLETED SUICIDE |
2 |
0.0000 |
| 79 |
POLLAKIURIA |
1 |
0.0000 |
| 80 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 81 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 82 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 83 |
SEPTIC SHOCK |
1 |
0.0000 |
| 84 |
LIVER DISORDER |
1 |
0.0000 |
| 85 |
BLOOD GLUCOSE INCREASED |
4 |
0.0000 |
| 86 |
ARRHYTHMIA |
1 |
0.0000 |
| 87 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 88 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 89 |
THERAPY CESSATION |
1 |
0.0000 |
| 90 |
ILLNESS |
2 |
0.0000 |
| 91 |
INFLAMMATION |
1 |
0.0000 |
| 92 |
ECZEMA |
1 |
0.0000 |
| 93 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 94 |
NECK PAIN |
1 |
0.0000 |
| 95 |
ABDOMINAL DISCOMFORT |
3 |
0.0000 |
| 96 |
FLATULENCE |
1 |
0.0000 |
| 97 |
DYSPHONIA |
1 |
0.0000 |
| 98 |
BONE PAIN |
1 |
0.0000 |
| 99 |
NASAL CONGESTION |
1 |
0.0000 |
| 100 |
PRODUCT USE ISSUE |
3 |
0.0000 |
| 101 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 102 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 103 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 104 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 105 |
INFECTION |
2 |
0.0000 |
| 106 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 107 |
HALLUCINATION |
1 |
0.0000 |
| 108 |
HOT FLUSH |
1 |
0.0000 |
| 109 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 110 |
ARTHRITIS |
1 |
0.0000 |
| 111 |
PARAESTHESIA |
2 |
0.0000 |
| 112 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 113 |
FALL |
4 |
0.0000 |
| 114 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 115 |
TOXICITY TO VARIOUS AGENTS |
2 |
0.0000 |
| 116 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 117 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 118 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 119 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 120 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 121 |
CONTUSION |
1 |
0.0000 |
| 122 |
DIZZINESS |
5 |
0.0000 |
| 123 |
FLUSHING |
1 |
0.0000 |
| 124 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 125 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 126 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 127 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 128 |
SEPSIS |
1 |
0.0000 |
| 129 |
DECREASED APPETITE |
2 |
0.0000 |
| 130 |
CHILLS |
1 |
0.0000 |
| 131 |
FEELING ABNORMAL |
2 |
0.0000 |
| 132 |
JOINT SWELLING |
1 |
0.0000 |
| 133 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 134 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 135 |
PRURITUS |
3 |
0.0000 |
| 136 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 137 |
HYPERHIDROSIS |
1 |
0.0000 |
| 138 |
PSORIASIS |
1 |
0.0000 |
| 139 |
RENAL FAILURE |
1 |
0.0000 |
| 140 |
DRY SKIN |
1 |
0.0000 |
| 141 |
VISION BLURRED |
1 |
0.0000 |
| 142 |
HOSPITALISATION |
1 |
0.0000 |
| 143 |
PNEUMONIA |
2 |
0.0000 |
| 144 |
TREMOR |
1 |
0.0000 |
| 145 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 146 |
COVID-19 |
1 |
0.0000 |
| 147 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 148 |
ASTHENIA |
2 |
0.0000 |
| 149 |
FATIGUE |
4 |
0.0000 |
| 150 |
ERYTHEMA |
1 |
0.0000 |
| 151 |
HEADACHE |
3 |
0.0000 |
| 152 |
DIARRHOEA |
3 |
0.0000 |
| 153 |
OVERDOSE |
1 |
0.0000 |
| 154 |
RASH |
2 |
0.0000 |
| 155 |
DEPRESSION |
1 |
0.0000 |
| 156 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 157 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 158 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 159 |
DRUG INEFFECTIVE |
5 |
0.0000 |
| 160 |
COUGH |
1 |
0.0000 |
| 161 |
DYSPNOEA |
2 |
0.0000 |
| 162 |
ANXIETY |
1 |
0.0000 |
| 163 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 164 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 165 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 166 |
PAIN |
2 |
0.0000 |
| 167 |
NAUSEA |
2 |
0.0000 |
| 168 |
ARTHRALGIA |
1 |
0.0000 |
| 169 |
VOMITING |
1 |
0.0000 |
| 170 |
OFF LABEL USE |
1 |
0.0000 |